Barreto-Andrade JC, Medina-Franco H

Language: English
References: 20
Page: 198-204
PDF size: 103.23 Kb.

ABSTRACT

Background. Soft tissue sarcomas are rare tumors with a wide clinical spectrum. Prognostic factors for survival have been identified, but they have been focused in the characteristics of the tumor. Patient related variables have not usually been considered in previous analysis. Methods. We analyzed a group of 61 patients with soft tissue sarcomas. Tumor related variables and patient related ones were recorded. Overall and disease free survival were calculated according to the Kaplan and Meier method. Prognostic factors for survival were determined by the log-rank method for univariate analysis and the Cox method for multivariate analysis. Results. Clinical and demographic characteristics are comparable to those of previous reports. Adverse prognostic factors for overall survival in multivariate analysis were advanced stage, high tumor grade, irresecability, and serum albumin. Size, high surgical risk (ASA III-IV) and a low performance status (Karnofsky less than 70) were predictive of overall survival only in univariate analysis. For disease free survival, only high tumor grade had statistical significance. Conclusions. Besides the usual tumor related prognostic factors, such as grade and stage, patient related factors, such as performance status and surgical risk should be considered when predicting survival. Specifically, serum albumin was an independent prognostic factor for overall survival.

REFERENCES

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.

2. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: metaanalysis of individual data. Lancet 1997; 350: 1647-54.

3. Bramwell V, Rouesse J, Steward W, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma–reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994; 12: 1137-49.

4. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-89.

5. Singer S, Corson JM, Demetri GD, Healey EZ, Marcus K, Eberlein T. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221: 185-95.

6. Collin C, Godbold J, Hajdu S, et al. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol 1988; 5: 601-12.

7. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma. Analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355-65.

8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.

9. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd. Ed. Oxford, UK: Blackwell Scientific Pub; 1987.

10. Cox D. Regression models and life-tables. J R Stat Soc 1972; 34(Ser. B):187-200.

11. Pollock RE, Karnell LH, Menck HR, Winchester DP. The National cancer database report on soft tissue sarcoma. Cancer 1996; 78: 2247-57.

12. Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212: 51-9.

13. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.

14. Baracos VE. Regulation of skeletal-muscle protein turnover in cancer-associated cachexia. Nutrition 2000; 16: 1015-8.

15. Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, et al. Serum albumin is a significant prognostic factor for patients with gastric adenocarcinoma. Ann Surg Onc 2006; 13: S35.

16. Medina-Franco H, Ramos-Gallardo G, Orozco-Zepeda H, Mercado- Diaz MA. Factores pronósticos en cáncer de vesícula. Rev Invest Clin 2005; 57: 662-5.

17. Aparicio J, Munarriz B, Pastor M, et al. Long-term follow-up and prognostic factors in Ewing’s sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology 1998; 55: 20-6.

18. Rougraff B, Sandler A. Karnofsky performance score as a predictor of survival in soft tissue sarcoma. Clin Orthop Relat Res 2002; 397: 196-203.

19. Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994; 219: 165-73.

20. Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tis sue sarcoma of the extremity? Ann Surg Oncol 2003; 10: 432-40.